INTERNATIONAL PATENT: OBI PHARMA, INC., CHEN, YA-CHI FILES APPLICATION FOR "GLYCOSYNTHASE MUTANTS FOR ANTIBODY-DRUG CONJUGATE ENGINEERING"

GENEVA, Dec. 10 -- OBI PHARMA, INC. (6F., No. 508, Sec. 7, Zhongxiao E. Rd.Nangang DistrictTaipei City, 115011), CHEN, Ya-Chi (7220 Trade Street, Suite 334San Diego, CA 92121) filed a patent application (PCT/US2025/031188) for "GLYCOSYNTHASE MUTANTS FOR ANTIBODY-DRUG CONJUGATE ENGINEERING" on May 28, 2025. With publication no. WO/2025/250633, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LAI, Ming-Tain (6F., No. 508, Sec. 7, Zhongxiao E. Rd.Nangang DistrictTaipei City, 115011), CHOU, Jun-Hong (6F., No. 508, Sec. 7, Zhon...